Quarterly Consolidated Balance Sheet

OncoTherapy Science, Inc. - Filing #7595079

Concept As at
2022-06-30
As at
2022-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,505,994,000 JPY
1,836,906,000 JPY
Work in process
51,044,000 JPY
107,941,000 JPY
Raw materials and supplies
86,909,000 JPY
123,101,000 JPY
Other
141,873,000 JPY
113,764,000 JPY
Current assets
1,957,913,000 JPY
2,600,551,000 JPY
Non-current assets
Property, plant and equipment
JPY
17,000 JPY
Property, plant and equipment
Investments and other assets
84,630,000 JPY
84,630,000 JPY
Investments and other assets
Non-current assets
84,630,000 JPY
84,648,000 JPY
Assets
2,042,544,000 JPY
2,685,199,000 JPY
Liabilities
Current liabilities
Income taxes payable
34,133,000 JPY
136,533,000 JPY
Other
39,837,000 JPY
24,008,000 JPY
Current liabilities
272,930,000 JPY
604,923,000 JPY
Non-current liabilities
Asset retirement obligations
99,992,000 JPY
99,703,000 JPY
Non-current liabilities
100,316,000 JPY
100,041,000 JPY
Liabilities
373,247,000 JPY
704,965,000 JPY
Net assets
Shareholders' equity
Share capital
789,114,000 JPY
789,114,000 JPY
Capital surplus
24,793,617,000 JPY
24,793,617,000 JPY
Retained earnings
-23,963,978,000 JPY
-23,686,179,000 JPY
Shareholders' equity
1,618,753,000 JPY
1,896,553,000 JPY
Share acquisition rights
50,543,000 JPY
83,680,000 JPY
Net assets
1,669,297,000 JPY
1,980,233,000 JPY
Liabilities and net assets
2,042,544,000 JPY
2,685,199,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.